Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Response to Corticosteroid Injection in Shoulder Osteoarthritis
NCT03232749Phase 4Terminated
- Sponsor
- University of Florida
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylprednisolone in osteoarthritis (OA), sponsored by University of Florida. Primary endpoints: American Shoulder and Elbow Surgeons Score at 6 months, Visual Analog Scale at 6 months and 1 more. Started Apr 2018; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03232749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232749.